OtherBASIC SCIENCE INVESTIGATIONS
Preparation, Biological Evaluation, and Pharmacokinetics of the Human Anti-HER1 Monoclonal Antibody Panitumumab Labeled with 86Y for Quantitative PET of Carcinoma
Tapan K. Nayak, Kayhan Garmestani, Kwamena E. Baidoo, Diane E. Milenic and Martin W. Brechbiel
Journal of Nuclear Medicine June 2010, 51 (6) 942-950; DOI: https://doi.org/10.2967/jnumed.109.071290
Tapan K. Nayak
Kayhan Garmestani
Kwamena E. Baidoo
Diane E. Milenic
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 6
June 2010
Preparation, Biological Evaluation, and Pharmacokinetics of the Human Anti-HER1 Monoclonal Antibody Panitumumab Labeled with 86Y for Quantitative PET of Carcinoma
Tapan K. Nayak, Kayhan Garmestani, Kwamena E. Baidoo, Diane E. Milenic, Martin W. Brechbiel
Journal of Nuclear Medicine Jun 2010, 51 (6) 942-950; DOI: 10.2967/jnumed.109.071290
Preparation, Biological Evaluation, and Pharmacokinetics of the Human Anti-HER1 Monoclonal Antibody Panitumumab Labeled with 86Y for Quantitative PET of Carcinoma
Tapan K. Nayak, Kayhan Garmestani, Kwamena E. Baidoo, Diane E. Milenic, Martin W. Brechbiel
Journal of Nuclear Medicine Jun 2010, 51 (6) 942-950; DOI: 10.2967/jnumed.109.071290
Jump to section
Related Articles
Cited By...
- Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
- Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma
- Development of a Carbon-14 Labeling Approach to Support Disposition Studies with a Pegylated Biologic
- PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted 89Zr-Labeled Panitumumab